{"disease":{"id":"progression-disease","name":"progression disease"},"drugs":{"marketed":[{"drug_id":"atorvastatin","indication_name":"Slow Progression of Coronary Artery Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lipitor","generic_name":"atorvastatin","company_name":"Pfizer Inc.","drug_phase":"marketed","molecular_target":"HMG-CoA reductase","drug_class":"HMG-CoA reductase inhibitor (statin)","quality_score":77,"revenue":"1000.0","mechanism":"Selective competitive inhibitor of HMG-CoA reductase, the rate-limiting enzyme in cholesterol synthesis."},{"drug_id":"azd5363","indication_name":"Triple-negative breast cancer with disease progression on or after chemotherapy in the neoadjuvant or adjuvant setting and/or in patients with measurable disease by RECIST v1.1","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Azd5363","generic_name":"azd5363","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"AKT","drug_class":"phosphatidylinositol 3-kinase (PI3K) inhibitor","quality_score":25,"revenue":null,"mechanism":""},{"drug_id":"fluvastatin","indication_name":"Slow Progression of Coronary Artery Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lescol","generic_name":"FLUVASTATIN","company_name":"Novartis","drug_phase":"marketed","molecular_target":"HMG-CoA reductase","drug_class":"HMG-CoA Reductase Inhibitor","quality_score":65,"revenue":null,"mechanism":"Fluvastatin sodium inhibits HMG-CoA reductase, reducing cholesterol biosynthesis and increasing LDL receptor activity, lowering plasma cholesterol."},{"drug_id":"simvastatin","indication_name":"Slow Progression of Coronary Artery Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Zocor","generic_name":"simvastatin","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Nuclear receptor subfamily 1 group I member 3, Nuclear receptor subfamily 4 group A member 2, 3-hydroxy-3-methylglutaryl-coenzyme A reductase","drug_class":"HMG-CoA Reductase Inhibitor [EPC]","quality_score":40,"revenue":null,"mechanism":null},{"drug_id":"myoinositol","indication_name":"Slow Progression of Coronary Artery Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Myoinositol","company_name":"University of Colorado, Denver","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":15,"revenue":null,"mechanism":null},{"drug_id":"lipitor","indication_name":"Slow Progression of Coronary Artery Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lipitor","generic_name":"Atorvastatin Calcium","company_name":"Pfizer","drug_phase":"marketed","molecular_target":"3-hydroxy-3-methylglutaryl-coenzyme A reductase","drug_class":"atorvastatin","quality_score":10,"revenue":null,"mechanism":"Lipitor is a selective, competitive inhibitor of HMG-CoA reductase, a key enzyme in cholesterol synthesis."},{"drug_id":"inositol","indication_name":"Slow Progression of Coronary Artery Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Inosital","generic_name":"INOSITOL","company_name":"","drug_phase":"discontinued","molecular_target":"","drug_class":"inositol","quality_score":null,"revenue":null,"mechanism":"Inosital works by influencing the metabolism of lipids in the body."},{"drug_id":"lovastatin","indication_name":"Slow Progression of Coronary Artery Disease","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mevacor","generic_name":"LOVASTATIN","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"3-hydroxy-3-methylglutaryl-coenzyme A reductase","drug_class":"HMG-CoA Reductase Inhibitor","quality_score":null,"revenue":null,"mechanism":"Mevacor works by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol production in the liver."}],"pipeline":[],"offLabel":[],"totalMarketed":8,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04525833","title":"Liver Disease and Other Systemic Diseases","phase":"","overall_status":"RECRUITING","enrollment_count":15000,"lead_sponsor_name":"Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation","has_results":false},{"nct_id":"NCT04213664","title":"Meta-analysis of the Prognostic Value of Lymphocyte to Monocyte Ratio (LMR) in Non-metastatic Renal Cell Carcinoma.","phase":"","overall_status":"UNKNOWN","enrollment_count":4666,"lead_sponsor_name":"Corporacion Parc Tauli","has_results":false},{"nct_id":"NCT06480617","title":"Observational, Bivariate Analysis of Clinical Big Data in Patients With Cervical Cancer","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":3000,"lead_sponsor_name":"Anhui Provincial Hospital","has_results":false},{"nct_id":"NCT03892577","title":"Real-world Study for Patients With Advanced Hepatobiliary Tumors","phase":"","overall_status":"UNKNOWN","enrollment_count":3000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06306170","title":"Advanced Radiotherapy (ART) in Gynecological Cancer Patients (GYN-ART)","phase":"","overall_status":"RECRUITING","enrollment_count":1000,"lead_sponsor_name":"IRCCS San Raffaele","has_results":false},{"nct_id":"NCT03349385","title":"Registry of Secondary Revascularization","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":869,"lead_sponsor_name":"Hospital San Carlos, Madrid","has_results":false},{"nct_id":"NCT04422223","title":"Prospective Cohort Study of Disease and Outcomes in Cirrhosis","phase":"","overall_status":"UNKNOWN","enrollment_count":550,"lead_sponsor_name":"Copenhagen University Hospital, Hvidovre","has_results":false},{"nct_id":"NCT05663242","title":"The Effects of Using Different Anesthetics on the Prognosis of Primary Lung Tumors and Its Mechanism of Action","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":300,"lead_sponsor_name":"Kaohsiung Medical University Chung-Ho Memorial Hospital","has_results":false},{"nct_id":"NCT06962891","title":"Validation of a Proteomic Biomarker to Predict Progression of Chronic Kidney Disease","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":213,"lead_sponsor_name":"Angel Argiles","has_results":false},{"nct_id":"NCT02241109","title":"Predicting Aortic Stenosis Progression by Measuring Serum Calcification Propensity","phase":"NA","overall_status":"COMPLETED","enrollment_count":200,"lead_sponsor_name":"Insel Gruppe AG, University Hospital Bern","has_results":false},{"nct_id":"NCT05383456","title":"The Visceral Adiposity Measurement and Observation Study","phase":"","overall_status":"COMPLETED","enrollment_count":196,"lead_sponsor_name":"Theratechnologies","has_results":false},{"nct_id":"NCT06918951","title":"Stereotactic Radiotherapy Versus Palliative Conventional Radiotherapy for Oligoprogressive Metastatic Cancers","phase":"NA","overall_status":"RECRUITING","enrollment_count":194,"lead_sponsor_name":"British Columbia Cancer Agency","has_results":false},{"nct_id":"NCT04879316","title":"Energy for Lymphocytes","phase":"","overall_status":"COMPLETED","enrollment_count":144,"lead_sponsor_name":"Hôpital Cochin","has_results":false},{"nct_id":"NCT05939362","title":"New Imaging Biomarkers Predictive of MA Progression","phase":"NA","overall_status":"RECRUITING","enrollment_count":80,"lead_sponsor_name":"Poitiers University Hospital","has_results":false},{"nct_id":"NCT06558084","title":"Real-World Clinical Outcomes and Toxicity in Metastatic Breast Cancer Patients Treated With First or Second Line CDK 4/6 Inhibitors and Endocrine Therapy","phase":"","overall_status":"COMPLETED","enrollment_count":64,"lead_sponsor_name":"Ain Shams University","has_results":false},{"nct_id":"NCT05704231","title":"The Effect of Telephone-Assisted Smoking Cessation Program in Patients Diagnosed With Non-Muscle Invasive Bladder Cancer","phase":"NA","overall_status":"UNKNOWN","enrollment_count":60,"lead_sponsor_name":"Bakirkoy Dr. Sadi Konuk Research and Training Hospital","has_results":false},{"nct_id":"NCT05024175","title":"Long-term Follow-up of Subjects Treated With CAR T Cells","phase":"","overall_status":"RECRUITING","enrollment_count":45,"lead_sponsor_name":"Marcela V. Maus, M.D.,Ph.D.","has_results":false},{"nct_id":"NCT05536206","title":"Continuous and Wireless Vital Sign Monitoring in Patients at Home After Acute Medical Admission","phase":"","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Bispebjerg Hospital","has_results":false},{"nct_id":"NCT03150602","title":"A Pralatrexate Study in Asian Patients With Peripheral T-cell Lymphoma After Prior Therapy","phase":"PHASE4","overall_status":"UNKNOWN","enrollment_count":22,"lead_sponsor_name":"Taiwan Mundipharma Pharmaceuticals Ltd.","has_results":false},{"nct_id":"NCT03469804","title":"Phase II Multicentric Study of Pembrolizumab in Classic or Endemic Kaposi's Sarcoma","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":17,"lead_sponsor_name":"Assistance Publique - Hôpitaux de Paris","has_results":false},{"nct_id":"NCT04754880","title":"Coronary Chronic Total Occlusion and Oxidative Balance","phase":"","overall_status":"COMPLETED","enrollment_count":1,"lead_sponsor_name":"Kahramanmaras Sutcu Imam University","has_results":false}],"total":21},"guidelines":[],"source":"Drug Landscape verified database"}